Does HUMAN C1-ESTERASE INHIBITOR Cause Poor venous access? 174 Reports in FDA Database

Q: Does HUMAN C1-ESTERASE INHIBITOR cause Poor venous access?

174 reports of Poor venous access have been filed with the FDA for HUMAN C1-ESTERASE INHIBITOR, representing 1.2% of all HUMAN C1-ESTERASE INHIBITOR adverse event reports.

Q: How dangerous is Poor venous access from HUMAN C1-ESTERASE INHIBITOR?

Of 174 reports, 2 (1.1%) resulted in death and 61 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 174 reports of Poor venous access have been filed in association with HUMAN C1-ESTERASE INHIBITOR (Cinryze). This represents 1.2% of all adverse event reports for HUMAN C1-ESTERASE INHIBITOR.

174

Reports of Poor venous access with HUMAN C1-ESTERASE INHIBITOR

1.2%

of all HUMAN C1-ESTERASE INHIBITOR reports

Deaths

Hospitalizations

How Dangerous Is Poor venous access From HUMAN C1-ESTERASE INHIBITOR?

Of the 174 reports, 2 (1.1%) resulted in death, 61 (35.1%) required hospitalization, and 2 (1.1%) were considered life-threatening.

Is Poor venous access Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HUMAN C1-ESTERASE INHIBITOR. However, 174 reports have been filed with the FAERS database.

What Other Side Effects Does HUMAN C1-ESTERASE INHIBITOR Cause?

Hereditary angioedema (5,572) No adverse event (1,660) Off label use (1,614) Drug ineffective (1,426) Intentional product use issue (1,117) Product use in unapproved indication (1,003) Weight increased (897) Maternal exposure during pregnancy (869) Pain (822) Condition aggravated (775)

What Other Drugs Cause Poor venous access?

VEDOLIZUMAB (1,043) INFLIXIMAB (917) INFLIXIMAB-DYYB (782) ECULIZUMAB (555) HUMAN IMMUNOGLOBULIN G (504) NATALIZUMAB (422) RITUXIMAB (299) TOCILIZUMAB (287) METHOTREXATE (257) ABATACEPT (249)

Which HUMAN C1-ESTERASE INHIBITOR Alternatives Have Lower Poor venous access Risk?

HUMAN C1-ESTERASE INHIBITOR vs HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX HUMAN C1-ESTERASE INHIBITOR vs HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN HUMAN C1-ESTERASE INHIBITOR vs HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN HUMAN C1-ESTERASE INHIBITOR vs HUMAN IMMUNOGLOBULIN G HUMAN C1-ESTERASE INHIBITOR vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE

HUMAN C1-ESTERASE INHIBITOR Full Profile All Poor venous access Reports All Drugs Causing Poor venous access HUMAN C1-ESTERASE INHIBITOR Demographics